GeoVax Labs (GOVX) EPS (Basic) Growth (1y) (2020 - 2026)
GeoVax Labs (GOVX) EPS (Basic) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | -16.29% |
| 10 | GeoVax Labs | 2.92 Mn | -220,776.39 | - | -177.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.06% |
| Dec 31, 2025 | 88.42% |
| Sep 30, 2025 | 64.16% |
| Jun 30, 2025 | 82.47% |
| Mar 31, 2025 | 81.87% |
| Dec 31, 2024 | 61.87% |
| Sep 30, 2024 | 80.89% |
| Jun 30, 2024 | 40.70% |
| Mar 31, 2024 | -7.48% |
| Dec 31, 2023 | 12.19% |
| Sep 30, 2023 | -87.30% |
| Jun 30, 2023 | -27.21% |
| Mar 31, 2023 | 55.10% |
| Dec 31, 2022 | 85.92% |
| Sep 30, 2022 | 44.95% |
| Jun 30, 2022 | 25.03% |
| Mar 31, 2022 | -16.50% |
| Dec 31, 2021 | -133.25% |
| Sep 30, 2021 | 57.85% |
| Jun 30, 2021 | 64.32% |